Randomized, controlled trial of thel effect of luseogliflozin in type 2 diabetic patients with fattiy liver
Not Applicable
- Conditions
- type 2 diabetic patients with fatty liver
- Registration Number
- JPRN-UMIN000016090
- Lead Sponsor
- Ichinomiyanichi hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.patients with renal failure 2.patients who have had cerebral infarction 3.patients who have had myocardial infarction 4.patients who is administered diuretics 5.patients who have dehydration 6.patient who is inadequate for this trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method A liver attenuation index at unen- hanced CT 24 week after administration
- Secondary Outcome Measures
Name Time Method liver enzyme, fasting plasma glucose ,and HbA1c 24week after administration